U.S. market Closed. Opens in 1 day 10 hours 29 minutes

ERNA | Eterna Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue68.00KN/AN/AN/A19.81M23.34M21.27M22.31M24.52M
Cost of Revenue236.00K497.00K459.00K98.00K7.84M8.38M7.09M8.13M13.06M
Gross Profit-168.00K-497.00K-459.00K-98.00K11.96M14.95M14.19M14.18M11.46M
Operating Expenses20.97M27.23M27.43M7.25M13.18M14.49M15.59M16.46M18.06M
Selling, General & Admin14.59M16.84M14.72M3.30M13.15M14.41M15.45M16.46M18.06M
Research & Development5.92M10.39M12.71M3.95M26.00K72.00K139.00KN/AN/A
Other Operating Expenses461.00K-1.17M899.00KN/AN/AN/AN/AN/AN/A
Operating Income-21.14M-33.22M68.34M-7.25M-1.21M464.00K-1.40M-2.28M-6.60M
Other Expenses / Income-536.00K8.68M-95.05M-19.28M-808.00K-787.00K391.00K-607.00K-614.00K
Before Tax Income-21.67M-24.53M-122.30M-7.29M-2.02M-323.00K-1.01M-2.88M-7.21M
Income Tax Expenses-3.00K45.00K5.00K-19.20M27.00K-64.00K66.00K38.00K12.00K
Net Income-21.67M-24.58M-122.31M11.91M-2.05M-259.00K-1.08M-2.92M-7.23M
Interest Expenses614.00K30.00K74.00K43.00K249.00K389.00K498.00K576.00K484.00K
Basic Shares Outstanding5.31M3.05M2.17M439.70K71.88K67.20K61.05K47.58K45.95K
Diluted Shares Outstanding5.31M3.05M2.17M439.70K71.88K67.20K61.05K47.58K45.95K
EBITDA-19.93M-33.22M-121.95M-7.15M1.96M3.23M915.00K609.00K-3.63M
EBITDA Margin-29,314.71%0.00%0.00%0.00%9.88%13.83%4.30%2.73%-14.79%
EBIT-21.06M-24.50M-122.23M-7.25M-1.77M66.00K-513.00K-2.31M-6.73M
EBIT Margin-30,966.18%0.00%0.00%0.00%-8.94%0.28%-2.41%-10.35%-27.45%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙